They coordinate with scientists and pharmaceutical officials to plan drug trials, facilitate drug research and interpret and report data to regulatory agencies. They make sure all activity that occurs ...

Although the regulatory landscape for advanced therapy medicinal products (ATMPs) is rapidly evolving, varying regulatory requirements across different regions are hindering cell and gene therapy (CGT ...

In this video interview, Thierry Escudier, portfolio lead, Pistoia Alliance, highlights where regulatory agencies currently ...

Advancements in drug manufacturing technologies are reshaping global regulatory frameworks. This shift is largely driven by the integration of artificial intelligence (AI)-powered models, cloud ...

The US FDA is coping with a series of Trump-imposed job cuts. These are starting to hamper food safety and pharmaceutical ...

"European agencies catch up with speedier regulatory pathways for CGTs in the US" was originally created and published by Pharmaceutical Technology, a GlobalData owned brand. The information on ...